In the training cohort, HER2-zero and HER2-low cancers differed significantly in BI-RADS category, histological grade, and ultrasound characteristics including external and internal CDFI, lesion margin, and posterior acoustic features (all p < .05). Here, ERBB2 is linked to cancer.